BioSpace News Archive

Employee philanthropy campaign impacting lives honored by California senior living organization

The Phase 1 trial of FOR46 in metastatic castration-resistant prostate cancer is planned to launch by the end of the year.

The “2018 Southwest Sports Marketing Report,” crafted and commissioned by leading marketing services agency LAVIDGE, reveals insights about consumer spending choices in this fast-evolving space.

The $1.35 Million Dollar Grant will Support Osteosarcoma Research

Initial project focuses on extending shelf life of whole wheat and promoting whole grain consumption

The first town to leverage trainings seeks to build resiliency amidst public health crisis

According to data compiled by Allied Market Research, the global remote patient monitoring market was valued at USD 703 Million in 2015 and is expected to reach USD 2.13 Billion by 2022.

“I’m an integrated medical practitioner and I thought there could be an improved treatment option for individuals suffering from immune deficiencies,” said an inventor, from Coral Springs, Fla., “so I invented the HEALTH REGENERATION THERAPEUTIC MODALITY.”

TELA Bio®, Inc., a surgical reconstruction company leading the development and commercialization of OviTex® Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced that the company has appointed Kurt Azarbarzin to its board of directors. Mr. Azarbarzin will replace vacating TELA Bio director Paul Touhey.

Tekni-Plex, Inc. has acquired Beyers Plastics, Puurs, Belgium, a cleanroom Class 7 extruder and converter of polyethylene (PE) film, from investment company FAMO N.V.